Last reviewed · How we verify
blood sampling for DNA — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
blood sampling for DNA (blood sampling for DNA) — Assistance Publique - Hôpitaux de Paris.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| blood sampling for DNA TARGET | blood sampling for DNA | Assistance Publique - Hôpitaux de Paris | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- blood sampling for DNA CI watch — RSS
- blood sampling for DNA CI watch — Atom
- blood sampling for DNA CI watch — JSON
- blood sampling for DNA alone — RSS
Cite this brief
Drug Landscape (2026). blood sampling for DNA — Competitive Intelligence Brief. https://druglandscape.com/ci/blood-sampling-for-dna. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing